Bioperfectus COVID-19 Solution Stays Effective Against "Omicron"
New variant B.1.1.529 (Omicron) was first identified in South Africa on Nov. 24, 2021, and has been classified as a variant of concern by WHO. With more than 30 mutation sites on the Spike protein, B.1.1.529 spreads even faster than Delta variant. Facing this contagious variant, Bioperfectus‘ COVID-19 solution, including RT-PCR Kits and Antigen RDT Kits, remains effective and reliable by silico-analysis and simulation experiments. All of our kits effectively show no drop-off in sensitivity and specificity in the face of the Omicron variant.